Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levornidazole PK/PD study in anaerobic intra-abdominal infection
ChiCTR1800015413Phase 4Completed
- Sponsor
- Wuxi Xishan People's Hospital
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levornidazole in Intra-abdominal infection (IAI), peritonitis, intra-abdominal abscess (IAA) and 1 more, sponsored by Wuxi Xishan People's Hospital. Primary endpoint: Blood concentration. Started Jul 2016; status: completed.
02
Drugs
levornidazole
03
Conditions
Intra-abdominal infection (IAI)peritonitisintra-abdominal abscess (IAA)hepatic abscess
Beyond the preview
Go deeper on ChiCTR1800015413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015413.